Sentinel Lymph Node Detection for Breast Cancer: Which Patients Are Best Suited for the Patent Blue Dye Only Method of Identification?

2001 ◽  
Vol 8 (5) ◽  
pp. 438-443 ◽  
Author(s):  
Claude Nos ◽  
Paul Fr�neaux ◽  
Sandrine Guilbert ◽  
Marie C. Falcou ◽  
Remi J. Salmon ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Blue Dye ◽  
Sentinel Lymph Node Detection ◽  
Patent Blue ◽  
Patent Blue Dye

Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin

Breast Cancer ◽  
2000 ◽  
Vol 7 (1) ◽  
pp. 87-94 ◽  
Author(s):  
Koichiro Tsugawa ◽  
Masakuni Noguchi ◽  
Koichi Miwa ◽  
Etsuro Bando ◽  
Kunihiko Yokoyama ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Gamma Probe ◽  
Lymph Node Biopsy ◽  
Blue Dye ◽  
Breast Cancer Patients ◽  
Patent Blue ◽  
Node Biopsy ◽  
Patent Blue Dye

scholarly journals Atypical Anaphylactic Reaction to Patent Blue During Sentinel Lymph Node Biopsy for Breast Cancer

2008 ◽  
Vol 90 (4) ◽  
pp. 338-339 ◽  
Author(s):  
Sophocles Lanitis ◽  
George Filippakis ◽  
Virinder Sidhu ◽  
Ragheed AL Mufti ◽  
Tak H Lee ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Sentinel Lymph Node Biopsy ◽  
Lymph Node Biopsy ◽  
Skin Tests ◽  
Blue Dye ◽  
Patent Blue ◽  
Node Biopsy ◽  
Patent Blue Dye

INTRODUCTION We present an unusual case of severe anaphylaxis to Patent Blue dye with atypical clinical features during sentinel lymph node biopsy (SLNB). The medical personnel involved with sentinel node biopsies should be alert, and familiar with this unusual entity. We also present current data from the literature. CASE REPORT During a wide local excision for primary breast cancer and SLNB, and early during the operation, the patient became severely tachycardic and hypotensive without any signs of urticaria, rash, oedema, or bronchospasm. Resuscitation required the addition of noradrenaline infusion followed by an overnight admission to the intensive care unit. Raised serum tryptase levels supported the diagnosis of anaphylactic shock while skin tests showed a severe reaction to Patent Blue dye. CONCLUSIONS Severe, life-threatening anaphylaxis to Patent Blue dye may present without obvious previous exposure to the dye and without the cardinal signs of oedema, urticaria and bronchospasm making the diagnosis and management of such cases challenging. Correct diagnosis and identification of the causative factor is important and requires a specific set of laboratory tests that are not commonly requested in every-day medical practice. It is not clear from the literature whether the condition is common enough to justify pre-operative prophylactic or diagnostic measures.

Anaphylaxis to patent blue dye during sentinel lymph node biopsy for breast cancer

2001 ◽  
Vol 27 (2) ◽  
pp. 218-219 ◽  
Author(s):  
M.H. Mullan ◽  
S.J. Deacock ◽  
N.F. Quiney ◽  
M.W. Kissin
Keyword(s):  
Breast Cancer ◽  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Sentinel Lymph Node Biopsy ◽  
Lymph Node Biopsy ◽  
Blue Dye ◽  
Patent Blue ◽  
Node Biopsy ◽  
Patent Blue Dye

scholarly journals Sentinel lymph node mapping with patent blue dye in patients with breast cancer: a retrospective single institution study

Gland Surgery ◽  
2021 ◽  
Vol 0 (0) ◽  
pp. 0-0
Author(s):  
Fabrice Olivier ◽  
Audrey Courtois ◽  
Veronique Jossa ◽  
Gaelle Bruck ◽  
Samy Aouachria ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Sentinel Lymph Node Mapping ◽  
Blue Dye ◽  
Single Institution ◽  
Lymph Node Mapping ◽  
Patent Blue ◽  
Patent Blue Dye
Sign in / Sign up

Export Citation Format

Share Document